CircRNF121 |
Oncogenic |
Overexpression |
miR-153-3p |
Wnt/β-catenin signaling |
CircRNF121 enhances cell proliferation and migration and suppresses autophagy through the miR-153-3p/ATF2 axis and wnt/β-catenin pathway |
[98] |
CircSAMD11 |
Oncogenic |
Overexpression |
miR-503 |
Wnt/β-catenin signaling |
CircSAMD11 enhances CC progression, cell proliferation, migration, and invasion and inhibits cell apoptosis by regulating the wnt/β-catenin pathway through the miR-503/SOX4 axis |
[99] |
Hsa_circ_0003204 |
Oncogenic |
Overexpression |
_ |
MAPK signaling pathway |
Hsa_circ_0003204 enhances cell proliferation and migration, and suppresses cell apoptosis via regulating the MAPK signaling |
[100] |
CircFAT1 |
Oncogenic |
Overexpression |
miR-409-3p |
MAPK signaling pathway |
CircFAT1 increases tumor growth and CC progression by enhancing the ERK1/2 and p38 of MAPK pathway through the miR-409-3p/CDK8 axis |
[101] |
Hsa_circ_0000515 |
Oncogenic |
Overexpression |
miR-326 |
MAPK signaling pathway |
Has_circ_0000515 induces cell proliferation and invasion, while represses apoptosis and autophagy by up-regulating the ELK1 through targeting miR-326 |
[102] |
Hsa_circ_CSPP1 |
Oncogenic |
Overexpression |
miR-361-5p |
PI3K/Akt/mTOR signaling pathway |
Hsa_circ_CSPP1 improves proliferation and invasion of CC through miR-361-5p/ITGB1 in PI3K-Akt signaling pathway |
[103] |
Hsa_circ_0001627 |
Oncogenic |
Overexpression |
miR-1225-5p |
PI3K/Akt/mTOR signaling pathway |
Hsa_circ_0001627 promotes CC progression via regulating the hsa_circ_0001627/miR-1225-5p/FNDC3B axis through the PI3K/mTOR pathway |
[104] |
Hsa_circ_0001495 |
Oncogenic |
Overexpression |
miR-526b-3p |
PI3K/Akt/mTOR signaling pathway |
Has_circ_0001495 increases cell proliferation and tumor growth, while decreases apoptosis by upmodulating the TMBIM6 through sponging miR-526-3p |
[105] |
CircCCDC134 |
Oncogenic |
Overexpression |
miR-503-5p |
_ |
ALKBH5-mediated m6A modification of circCCDC134 leads to circCCDC134 overexpression, which enhances the CC progression and metastasis by promoting the HIF1A-induced angiogenesis |
[106] |
Circ_0006646 |
Oncogenic |
Overexpression |
miR-758-3p |
_ |
Circ_0006646 improves CC progression and metastasis by enhancing the expression of RRM2 by sponging miR-758-3p |
[107] |
Circ_0001823 |
Oncogenic |
Overexpression |
miR-613 |
_ |
Circ_0001823 promotes cell viability and invasion leading to improved metastasis of CC by increasing the expression of RAB8A through sponging miR-613 |
[108] |
Hsa_circ_0005358 |
Tumor suppressive |
Under-expression |
_ |
_ |
Hsa_circ_0005358 suppresses CC progression and metastasis by blocking the interaction between PTBP1 and CDCP1 and decreasing CDCP1 expression |
[109] |
CircLMO1 |
Tumor suppressive |
Under-expression |
miR-4291 |
_ |
CircLMO1 enhances CC metastasis by inducing ferroptosis and apoptosis of CC cells through sponging miR-4291 |
[110] |
CircVPRBP |
Tumor suppressive |
Under-expression |
miR-106b-5p |
_ |
CircVPRBP suppresses CC metastasis and progression through the miR-106b-5p/TRIM3 axis |
[111] |
CircPVT1 (Hsa_circ_0009143) |
Oncogenic |
Overexpression |
miR-1286 |
_ |
CircPVT1 stimulates migration and invasion, and thus pulmonary metastasis. Also, it promotes EMT by sponging miR-1286, in an exosome-dependent manner |
[112] |
Circ-0000745 |
Oncogenic |
Overexpression |
_ |
_ |
Circ-0000745 upregulation leads to poor differentiation and vascular/lymphatic invasion |
[113] |
Circ-000284 |
Oncogenic |
Overexpression |
miR-506 |
_ |
Circ-000284 induces tumor growth and invasion by sponging miR-506, and subsequent regulation of Snail-2 |
[97] |
Circ-NRIP1
|
Oncogenic |
Overexpression |
miR-629-3p |
_ |
Circ-NRIP1 triggers the migration and invasion by inhibiting the PTP4A1/ ERK1/2 through sponging miR-629-3p |
[114] |
Circ-0003204 |
Oncogenic |
Overexpression |
_ |
MAPK signaling pathway |
Circ-0003204 induces tumor growth, migration, and invasion by regulating the MAPK signaling |
[100] |
CircUBAP2 |
Oncogenic |
Overexpression |
miR-361-3p |
_ |
CircUBAP2 provokes tumor growth and metastasis by targeting the miR-361-3p/SOX4 axis |
[115] |
Hsa_circRNA_0001400 |
Oncogenic |
Overexpression |
miR-326 |
PI3K-Akt signaling pathway |
Hsa_circRNA_0001400 improves CC cell proliferation and decreases apoptosis by enhancing the PI3K-Akt signaling pathway |
[116] |
Circ_0000263 |
Oncogenic |
Overexpression |
miR-1179 |
_ |
Circ_0000263 enhances CC progression by reducing cell apoptosis and amplifying cell proliferation through the miR-1179/ABL2 axis |
[117] |
CircRNA_0000285 |
Oncogenic |
Overexpression |
miR-654-3p |
_ |
CircRNA_0000285 suppresses miR-654-3p expression leading to increased cell viability, reduced cell apoptosis, and suppressed CC progression |
[118] |
Hsa_circ_0001038 |
Oncogenic |
Overexpression |
miR-337-3p |
_ |
Has_circ_0001038 induces tumor growth, migration, lymph node and myometrial invasion, while suppresses apoptosis by affecting MACC1 and CNNM3 in a miR-337-3p-dependent manner |
[119] |
Circ_0003221 |
Oncogenic |
Overexpression |
miR‑139‑3p |
_ |
Circ_0003221 promotes CC angiogenesis and progression via positive enhancing of S100A14 expression through sponging miR-139-3p |
[120] |